The rise and fall of raloxifene use for osteoporosis, 1999-2022
Shogry FF, Hayes KN, Kim S, Burden AM, Tadrous M, Aggarwal S, Cadarette SM. Osteoporos Int. 2025; Jun 11 [Epub ahead of prin]t.
Publications
Limited durability of protection conferred by XBB.1.5 vaccines against omicron-associated severe outcomes among community-dwelling adults, Ontario, Canada
Lee N, Nguyen L, Nasreen S, Austin PC, Brown KA, Buchan SA, Grewal R, Schwartz KL, Tadrous M, Wilson K, Wilson SE, Kwong JC; Canadian Immunization Research Network (CIRN) Investigators. Vaccine. 2025; May 26 [Epub ahead of print].
Practice facilitation to support primary care physicians with COVID-19 vaccine uptake: a randomized clinical trial
Shuldiner J, Shah NH, Bar-Ziv S, Kaplan, D, Green M, Bahniwal R, Bogoch, Nowak DA, Desveaux L, Taljaard M, Presseau J, Witteman H, Lofters A, Kiran T, Mauti J, Gill S, Chistie J, Tsang D, Tradrous M, Warshafsky D, Hu J, Vohra-Miller S, Ivers N. JAMA Netw Open. 2025; 8(5):e259967. Epub 2025 May 1.
Days at home for older adults receiving a remote monitoring intervention compared with usual home care recipients
Salahub C, Austin PC, Bai L, Ivers NM, Jones A, Tadrous M, Tran J, Lapointe-Shaw L. J Am Med Dir Assoc. 2025; 105611. Epub 2025 Apr 29.
Real-world comparative effectiveness and safety of pertuzumab in patients with HER2+ metastatic breast cancer: a pan-Canadian population-based cohort study
Muñoz CE, Dai WF, Cheung WY, de Oliveira C, Pataky RE, Ding PQ, Tran DA, Aurangzeb Z, Nagamuthu C, Liu N, Lethbridge L, McClure C, Vriends K, Xiong H, Folkins C, Somayaji C, Peacock S, Alvi R, Turner D, O’Conaill C, McDonald T, Urquhart R, Kendell C, Dowden J, Strumpf E, Denburg A, Beca JM, Mercer RE, Tadrous M, Takhar P, Chan KKW; CanREValue Collaboration. Int J Cancer. 2025; Apr 23 [Epub ahead of print].
Trends in the cost and utilization of publicly reimbursed cancer medications dispensed as take-home treatments from 2017-2021
Garg R, Dumont T, McCormack D, Tadrous M, Campbell T, Chan K, Gomes T. Curr Oncol. 2025; 32(4):237.
Trends in the cost and utilization of publicly dispensed respiratory inhalers in Ontario, Canada: a repeated cross-sectional study
Garg R, Wang T, Tadrous M, Antoniou T, Gomes T. Pharmacoepidemiol Drug Saf. 2025; 34(4):e70125.
Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study
Iskandar RJ, Tadrous M, Nguyen P, Dolovich L, Green M, Frymire E, Drucker AM. Br J Dermatol. 2025; Apr 2 [Epub ahead of print].
Systemic therapies for psoriatic disease and serious infections in older adults
Drucker AM, Sutradhar R, Ling V, Gatley JM, Eder L, Fahim C, Fralick M, Gomes T, Li P, MacDougall S, Manolson M, Rochon PA, Tadrous M. JAMA Dermatol. 2025; Mar 19 [Epub ahead of print].
Pathways of care following opioid overdose among people with opioid use disorder: a multilevel cohort study
Ledlie S, Tadrous M, Bayoumi AM, McCormack D, Besharah J, Munro C, Campbell T, Gomes T. Drug Alcohol Depend. 2025; Mar 8 [Epub ahead of print].